Biomimetic nanoparticles camouflaged with M2 macrophage membrane for osteoporosis therapy: A triple-action strategy that upregulates anti-inflammation and osteogenic responses while suppressing MMP-9
In an ovariectomized mouse model of osteoporosis, ZCM2 markedly improved bone microarchitecture, promoted new bone formation, and effectively inhibited bone resorption activity, offering a multifaceted synergistic therapeutic strategy for osteoporosis.
Abstract
Osteoporosis is a systemic skeletal disorder characterized by bone loss and microstructural deterioration, and its pathogenesis is closely associated with dysregulation of the bone marrow immune microenvironment. In this study, bioinformatic analysis first revealed significant oxidative stress and mitochondrial metabolic dysfunction in macrophages within the osteoporotic microenvironment. Based on this, we constructed a biomimetic nanoplatform (ZCM2) composed of ZIF-8@CaCO3 core–shell nanoparticles camouflaged with M2 macrophage membranes, designed to achieve comprehensive osteoporosis therapy through a triple synergistic mechanism: the ZIF-8 core scavenges reactive oxygen species to exert antioxidant and anti-inflammatory effects, inhibits MMP-9 secretion to reduce pathological bone resorption, and the CaCO3 shell releases calcium ions to promote osteogenic differentiation. ZCM2 exhibited favorable biosafety, high cellular uptake efficiency, and excellent bone-targeting capability. Mechanistic studies demonstrated that ZCM2 upregulates the expression of Nrf2 and HO-1, downregulates the expression of NF-κB p65, and significantly reduces the secretion of matrix metalloproteinase-9 (MMP-9) by macrophages, thereby attenuating bone resorption. Meanwhile, calcium ions released from the CaCO3 shell activate the RUNX2/OSX/OPN signaling axis, promoting osteogenic differentiation of bone marrow mesenchymal stem cells. In an ovariectomized mouse model of osteoporosis, ZCM2 markedly improved bone microarchitecture, promoted new bone formation, and effectively inhibited bone resorption activity. Collectively, this biomimetic nanoplatform integrates anti-inflammatory, anti-resorptive, and pro-osteogenic functions, offering a multifaceted synergistic therapeutic strategy for osteoporosis.
Osteoporosis is characterized by an imbalance in bone metabolism and reduced bone mass, with its pathogenesis closely linked to chronic inflammation and oxidative stress. These factors can promote macrophage polarization towards the bone-resorptive M1 phenotype. Targeting this pathological microenvironment, this study...
Ying Wang, Ling-Yu Liu, Xiang-Yu Hao et al.· Journal of materials chemist...· 0 citations
Osteoporosis is a prevalent metabolic bone disorder characterized by impaired bone formation, excessive bone resorption, and progressive microarchitectural deterioration. Oxidative stress and its associated mitochondrial dysfunction are important contributors to osteoblast apoptosis and osteoclast activation. Therefore...
Hong-Zhong Xi, Su Yan, Yu-Jiang Liu et al.· Biomaterials Advances· 0 citations
Periodontitis is a chronic inflammatory disease driven by dysregulated host immune responses. Macrophages, as key innate immune cells, play important roles in periodontal inflammation and bone homeostasis, and M2-like macrophage polarization has been associated with improved osteogenic differentiation of bone marrow me...
Juan Zhang, Cheng-Long Yin, Jing-Hong Chen et al.· Journal of Biomedical Materi...· 0 citations
Osteoporosis is characterized by dysregulated bone remodeling driven by excessive osteoclast-mediated bone resorption and insufficient osteoblast-mediated bone formation, often exacerbated by chronic inflammation and oxidative stress. Current pharmacological therapies remain limited by suboptimal efficacy and adverse e...
Yi-Min Du, Yue Zhang, Zi Wang et al.· Materials Today Bio· 0 citations
Postmenopausal osteoporosis (PO) is not merely a consequence of increased osteoclast activity. Estrogen deficiency induces oxidative stress and pro-inflammatory M1 macrophage polarization in bone tissue, thereby sustaining osteoclastogenic stimuli and pathological bone resorption. Interferon regulatory factor 5 (IRF5)...
Diabetic bone defects (DBDs) are typified by persistent inflammation, oxidative stress, and microbial infection within the diabetic microenvironment, which collectively hinder osteogenesis and angiogenesis. Herein, we introduce an Immunometabolic–Hyperthermia Therapy (IMHT) strategy based on a dual-functional nanoplatf...